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Abstract
Vitamin K is a fat-soluble vitamin that plays important roles in blood coagulation and bone metabolism. One of its functions
is as a co-factor for c-glutamyl carboxylase (Ggcx). Conventional knockout of Ggcx causes death shortly after birth in
homozygous mice. We created Ggcx-floxed mice by inserting loxP sequences at the sites flanking exon 6 of Ggcx. By mating
these mice with albumin-Cre mice, we generated Ggcx-deficient mice specifically in hepatocytes (GgcxDliver/Dliver mice). In
contrast to conventional Ggcx knockout mice, GgcxDliver/Dliver mice had very low activity of Ggcx in the liver and survived
several weeks after birth. Furthermore, compared with heterozygous mice (Ggcx+/Dliver), GgcxDliver/Dliver mice had shorter life
spans. GgcxDliver/Dliver mice displayed bleeding diathesis, which was accompanied by decreased activity of coagulation
factors II and IX. Ggcx-floxed mice can prove useful in examining Ggcx functions in vivo.
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Introduction
Vitamin K is a fat-soluble vitamin, which is involved in blood
coagulation and bone metabolism. One of the major functions of
vitamin K is its role as a co-factor for c-glutamyl carboxylase
(Ggcx) [1]. Ggcx is responsible for the posttranslational modifica-
tion of glutamic acid (Glu) residues into c-carboxyglutamic acid
(Gla) by its carboxylase activity. Hitherto, 19 kinds of Gla proteins
have been found, that is, coagulation factors II, VII, IX, and X;
protein C, protein S, and protein Z [2]; osteocalcin [3];
nephrocalcin [4]; matrix Gla protein [5]; growth arrest specific-6
(Gas6) [6]; periostin [7]; bIg-H3 [7]; proline-rich Gla protein 1
and 2 [8]; transmembrane Gla protein 3 and 4 [9]; upper zone of
growth plate and cartilage matrix associated protein (UCMA; also
called Gla-rich protein, GRP) [10]; and Ggcx itself, which was also
shown to be c-carboxylated [11]. Considering the various
expression sites and functions of these Gla proteins, it is indicated
that vitamin K is involved in many physiological and pathological
processes by activating Ggcx.
On the other hand, we have previously demonstrated c-
carboxylation-independent vitamin K function, in which vitamin
K is involved in the transcriptional regulation of nuclear receptor
SXR/PXR [12]. We reported that SXR/PXR-dependent vitamin
K functions are actually involved in the biological process in
osteoblasts [13] and hepatocellular carcinoma cells [14].
To fully understand the function of vitamin K, it is vital to
separate Ggcx-dependent and SXR/PXR-dependent vitamin K
functions. Analysis of Ggcx knockout mice would be useful in
examining Ggcx-dependent vitamin K functions in each tissue;
however, this attempt has been hampered by the fact that Ggcx
knockout mice die between embryonic day 9.5 and 18, and the few
that survive to term die shortly after birth [15]. To overcome this
limitation, we generated Ggcx-floxed mice that enabled organ
specific deficiency of Ggcx when bred with transgenic Cre mice
that showed organ-specific expression of Cre recombinase. Here,
we report a phenotype with liver-specific deficiency of Ggcx.
Materials And Methods
Ethics Statement
This study was carried out in strict accordance with the consent
of the Animal Care and Use Committees of Osaka University and
Saitama Medical University. The protocol was approved by the
Committee on the Ethics of Animal Experiments of the University
of Osaka (Protocol Number: 2003G004) and Saitama Medical
University (Protocol Number: 797).
Targeting Vector Construction
A targeting vector was constructed using pNT1.1 containing
two loxP sequences, a phosphoglycerate kinase (pgk)-neomycin
selectable marker cassette (neomycin cassette), and a herpes
simplex virus thymidine kinase gene. A mouse 129 strain l
genomic library (Stratagene) was purchased and digested with
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NotI. Genomic fragments were subcloned into pBluescript SK(+).
The 59 homology arm of the construct was derived from an
Asp718/HindIII genomic fragment containing intron 4, exon 5,
and intron 5 of Ggcx. This fragment was subcloned into pBluescript
SK(+) and then inserted into the 59 region of pNT1.1 between the
NotI and SalI sites. The 39 homology arm of the construct was
derived from a genomic fragment containing intron 6, exon 7, and
intron 7 of Ggcx. This fragment was amplified with primers 59-
GCTTAATTAAATGCATATAAGACAAGCACC-39 and 59-
ATGGTACCTAGGAAAGCAGGAAGAAG-39 and inserted in-
to the 39 region of pNT1.1 at the PacI and Asp718 sites. The
genomic region containing exon 6 was amplified with primers
59-AAGCTTGCAGGTGATTCTCC-39 and 59-ATGCATAAA-
ACAGAAAAAGTGAGCAAGCC-39; it was then inserted into
pNT1.1 at a BamHI site between the 59-loxP site and neomycin
cassette. This resulted in a targeting vector with a neomycin
cassette between exon 6 and 7 and a thymidine kinase gene
located downstream of the 39 homology region. The targeting
construct was linearized with NotI and electroporated into D3 ES
cells [16].
Generation of Ggcxflox/flox mice
Colonies of ES cells carrying the recombinant allele were
screened using 150 mg/ml of G418 and negatively selected using
2 mM gancyclovir. Selected cells were amplified and genomic
DNA was screened by Southern blot analysis. The ES cell lines
carrying the recombinant allele were subsequently used to
generate chimeras by injection into 129/Sv blastocysts. The
chimeric mice were mated with wild type C57BL/6N mice. The
F1 agouti offspring were analyzed for homologous recombination
by Southern blotting and PCR analysis. The F1 offspring were
backcrossed to C57BL/6N mice for more than eight generations
to generate Ggcxflox/+ mice with a C57BL/6N genetic background.
Ggcxflox/+ mice were intercrossed to generate Ggcxflox/flox mice
containing homozygous recombinant alleles.
Generation of hepatocyte-specific Ggcx-deficient mice
C57BL6/J mice containing transgenic constructs of mouse
albumin enhancer/promoter and Cre recombinase modified to
include a nuclear localization sequence (Alb-Cre) were purchased
from the Jackson Laboratory. ROSA26-LacZ reporter mice were
also obtained from the Jackson Laboratory. Hepatocyte-specific
expression of Cre recombinase was confirmed by mating Alb-Cre
mice with ROSA26-LacZ mice and assessing the b-galactosidase
activity of the expressed LacZ gene, which is expected to be
detected in cells expressing functional Cre recombinase. To
generate hepatocyte-specific Ggcx-deficient mice (GgcxDliver/Dliver),
Alb-Cre mice were mated with Ggcxflox/flox mice and F1 offspring
were subsequently intercrossed.
Southern blotting
EcoRI digested genomic DNA—derived from ES cells or tail
specimens—was electrophoresed through a 0.6% agarose gel,
transferred to a Hybond N+ membrane (Amersham Bioscience),





ACCATCATGTTTCTGGG) in exon 3 of the Ggcx gene.
Genotyping
Genomic DNA derived from tail specimens was used as the
template for PCR analysis. Tail cut was done before 3 weeks old or
immediately after the mice died. The Cre recombinase gene was
detected by amplifying a 654-bp fragment within the Cre gene with
primers 59-CCTGGAAAATGCTTCTGTCCGTTTGCC-39
and 59-GAGTTGATAGCTGGCTGGTGGCAGATG-39. The
loxP sequence was detected by amplifying the Ggcx sequence with
primers 59-AACTTAGGGAGTTGGTTCTCTTTCACTT-39
and 59-AATCCAATACACCCAAGGTCTTATTCAT-39 in in-
tron 5, containing loxP and linker sequences, to yield a 454-bp
fragment from the loxP-containing allele and 407-bp fragment
from the wild type allele. Deletion of exon 6 in the liver was
confirmed with primers 59- CGTGTACTTCATCGCGGGTG-
39 within exon 6 and 59-TCTGTATCCGGCTGAACGGG-39
within intron 6. DNA samples derived from liver, spleen, kidney
and heart of both GgcxDliver/Dliver mice and control Ggcx+/+ mice.
The DNA samples of same concentration (3 ng/ml) were used as
templates for PCR analysis.
Animal experiments
Mice were housed in a temperature-controlled room (22uC)
with a 12-h light/dark schedule, had free access to water, and were
fed standard laboratory chow. When mice were sacrificed,
anesthesia with an intraperitoneal injection of 2.5% avertin was
employed to minimize suffering of animals. Exsanguination was
done following anesthesia to ensure death.
Ggcx activity assay
FLEEL was purchased from Bachem (Philadelphia, PA). La-
phosphatidylcholine (type VE) and CHAPS were obtained from
Sigma Aldrich Japan (Tokyo, Japan). Vitamin K2 (menaquinone-
4) was obtained from Eisai Co., Ltd. (Tokyo, Japan). The peptide
ProFIX19, which contains the sequence AVFLDHENAN-
KILNRPKRY, was synthesized by Genenet Co., Ltd. (Fukuoka,
Japan). NaH14CO3 (specific activity, 58 mCi/mmol) was obtained
from Amersham Biosciences Corp. (NJ).
Six-week old mice were anesthetized with an intraperitoneal
injection of 2.5% avertin and the livers were excised for
measurement of Ggcx activity. Mice were euthanized by
exsanguination following liver excision. The Ggcx activity was
measured as previously described [17]. The amount of 14CO2
incorporated into exogenous substrates was measured in reaction
mixtures of 125 ml containing substrate (3.6 mM FLEEL), 222 mM
reduced vitamin K (vitamin KH2), 16 mM propeptide ProFIX19,
1.4 mM NaH14CO3 (5 mCi), 25 mM MOPS (pH 7.0), 500 mM
NaCl, 0.16% (w/v) phosphatidylcholine, 0.16% (w/v) CHAPS,
8 mM DTT, and 0.8 M ammonium sulfate, unless stated
otherwise. All of the assay components, except for the microsomal
fraction, were prepared as master mixes. 14CO2 incorporation into
peptide substrates (after an incubation period of over 30 min) was
assayed using a scintillation counter. All assays were performed in
quadruplicate.
Coagulation factor activity assay
Blood was collected from 6-week-old mice under anesthesia
with an intraperitoneal injection of 2.5% avertin. Collected blood
was immediately combined with one-tenth volume of 110 mM
sodium citrate. Plasma was isolated by centrifugation for 15 min at
25006g. The obtained plasma was analyzed with an automated
blood coagulation analyzer (STA Compact, Roche, Basel,
Switzerland) to determine factor II and IX activity using
prothrombin (factor II) or factor IX-deficient plasma.
Phenotype of Liver-Specific Ggcx-Deficient Mice
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Bleeding test
Four-week-old mice were anesthetized with an intraperitoneal
injection of 2.5% avertin. Their tails were cut to yield the same
wound diameters. To evaluate bleeding time, filter paper was
applied to the edge of the wound every minute, taking care not to
dislodge the clot.
Hematological examination
Two ml of blood was collected from 6-week-old mice under
anesthesia with an intraperitoneal injection of 2.5% avertin.
Collected blood was mixed with anti-coagulants (1 mg of EDTA-
2K and 20 ml of 3% EDTA-3K). The number of platelets was
measured using the Advia 120 (Bayer, Dublin, Ireland).
Life span analysis
To evaluate lifespan, mice were kept with their littermates. Male
and female mice were kept in separate cages without mating. They
were kept until either natural death, or evidence of impending
mortality necessitating euthanasia, such as unresponsiveness to
touch, slow respiration, coldness to touch, a hunched up position
with matted fur. Condition of the mice was monitored every two
days.
Statistical analysis
Data are expressed as mean 6 SEM. Differences between the
mean values were analyzed using the unpaired Student’s t-test.
Survival rates were plotted using the Kaplan-Meier method.
Survival differences between the groups were analyzed using the
log-rank test, for which p-values were adjusted by the Bonferroni
method.
Results
Generation of hepatocyte-specific Ggcx-deficient mice
The mouse c-glutamyl carboxylase (Ggcx) gene consists of 15
exons (Figure 1A). To disrupt the Ggcx gene, the targeting vector
was designed to flank exon 6 with two loxP sequences, and a
frameshift was generated by excision with Cre recombinase
(Figure 1A). Insertion of loxP sequences by homologous recombi-
nation was confirmed with Southern blotting analysis (Figure 1B).
To delete the Ggcx gene in the liver alone, albumin-Cre (Alb-Cre)
transgenic mice were used. The cre recombinase gene is under the
control of the albumin promoter, which is active only in
hepatocytes from E16.5 embryos [18] and the full activity was
exhibited at 2 months after birth [19]. To confirm the specificity of
recombination, the Alb-Cre mice were crossed with ROSA26-
LacZ mice, which contain a reporter gene in which b-galactosi-
dase is expressed in any tissue, and expression is dependent on
Cre-mediated recombination. b-galactosidase activity was detected
in the hepatocytes of offspring born from the mating of Alb-Cre
with ROSA26-LacZ mice (Figure 2A); these offspring also showed
Cre-recombinase activity in hepatocytes. Alb-Cre mice were then
mated with Ggcx-floxed mice (Ggcxflox/flox) and the resulting F1
offspring were intercrossed. To examine the genotypes of the F2
offspring, the Cre recombinase gene and the loxP-containing
region of the Ggcx gene were amplified by PCR using genomic
DNA prepared from tail samples. Some mice that expressed Cre
recombinase and carried homozygous floxed alleles were consid-
ered to be liver-specific Ggcx-deficient mice (GgcxDliver/Dliver mice)
(Figure 2B). They were born alive and survived for at least
several weeks. To confirm the ablation of Ggcx in the livers of
GgcxDliver/Dliver mice, genomic DNA was extracted from liver
and other organs (spleen, kidney and heart) from 6-week old
GgcxDliver/Dliver mice and control Ggcx+/+ mice. Decreased intensity
of PCR products from exon 6 was observed in only livers of
GgcxDliver/Dliver mice (Figure 2C). Next, vitamin K-dependent Ggcx
activity was measured in the livers of 6-week old GgcxDliver/Dliver
mice and control littermates (Ggcx+/+ mice). Ggcx activity was
significantly decreased in the livers of GgcxDliver/Dliver mice
(Figure 2D). There was no significant difference in Ggcx activity
between male and female GgcxDliver/Dliver mice.
Bleeding diathesis in GgcxDliver/Dliver mice
To examine the effect of decreased Ggcx activity in the livers of
GgcxDliver/Dliver mice, the activities of vitamin K-dependent coagu-
lation factors were examined. Activities of factors II and IX were
significantly decreased in GgcxDliver/Dliver mice, compared with
control (Ggcx+/+) mice (Figure 3A). Decreased activity of vitamin
K-dependent coagulation factor caused bleeding diathesis in
GgcxDliver/Dliver mice. Wild-type mice ceased bleeding within 10
minutes of tail incision, while GgcxDliver/Dliver mice continued to
bleed for more than 30 minutes (Figure 3B). The platelet count
was not significantly different between wild type mice and
GgcxDliver/Dliver mice (Figure 3C), suggesting the longer bleeding
time in GgcxDliver/Dliver mice was due to defective secondary
coagulation.
Shorter life span of GgcxDliver/Dliver mice
As a result of bleeding diathesis, injury and pregnancy caused
fatal bleeding in GgcxDliver/Dliver mice. In 9-week-old GgcxDliver/Dliver
mice, massive subcutaneous bleeding was observed even before
death. Dissection of pregnant GgcxDliver/Dliver mice just after death
revealed uterine as well as vaginal bleeding. Next, we evaluated
the life span of GgcxDliver/Dliver mice by keeping them separately
without mating. Male GgcxDliver/Dliver mice began to die from day 27
after birth, and all GgcxDliver/Dliver male mice died within 80 days
after birth (Figure 4). Female GgcxDliver/Dliver mice began to die from
day 39 after birth and 7 out of 11 (63.6%) survived longer than
100 days, unless they became pregnant (Figure 4). None of the
control heterozygous littermates (Ggcx+/Dliver mice) died within the
100 days of the observation period. The shorter life span of male
GgcxDliver/Dliver mice was statistically significant compared with male
heterozygous littermates. The cause of death seemed to be anemia
secondary to bleeding, since subcutaneous bleeding was observed
in some GgcxDliver/Dliver mice before death. Interestingly, female
GgcxDliver/Dliver mice survived significantly longer than male
GgcxDliver/Dliver mice.
Discussion
Mediation of post-transcriptional modification of substrate
proteins by Ggcx is one of the major functions of vitamin K. So
far, 19 proteins are known to be substrates of Ggcx and are
expressed throughout body, indicating various physiological
functions of vitamin K.
In the present study, we showed that liver-specific deficiency of
Ggcx caused bleeding diathesis and short life span. We consider
the massive bleeding in subcutaneous tissue or body cavity is a
direct cause of death since we observed massive subcutaneous
bleeding in most of the dead mice. It is also possible that local
bleeding in vital organs such as brain can cause death due to
bleeding diathesis.
Short life span of liver-specific Ggcx-deficient mice in the
present study along with the clinical presentation of vitamin K
deficiency indicate the relative importance of hepatic coagulation
factors among Ggcx substrates. Coagulation factors II, VII, IX,
and X are known to be vitamin K dependent. Therefore, we
considered the decreased activity of these coagulation factors to be
Phenotype of Liver-Specific Ggcx-Deficient Mice
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responsible for the Ggcx-deficient phenotype. Interestingly,
although the activity of factors II and IX was decreased in
GgcxDliver/Dliver mice, they live much longer than those with a
systemic lack of Ggcx. Most mice systemically lacking Ggcx die
between embryonic day 9.5 and 18, and the few that survive to
term die shortly after birth [15]. Among mice in which genes for
vitamin K-dependent coagulation factors had been knocked out,
factor II-deficient mice [20] and factor X-deficient mice [21] are
partial embryonic lethal. In factor II-deficient fetuses, abnormal
phenotypes such as pale yolk sac membrane, empty blood vessels,
enlarged pericardial sacs, and distended hearts were observed,
which appeared from embryonic day 9.5 to 12.5. In factor X-
deficient mice, some fetuses began to die of massive bleeding from
embryonic day 11.5 to 12.5, but the blood vessels and yolk sacs of
these mice were normal. Considering the phenotypes of factor II-
deficient and factor X-deficient mice, it can be inferred that the
embryonic lethal phenotype of systemic Ggcx-deficient mice is
likely due to abnormalities that developed at midgestation. In the
present study, we used an albumin promoter to regulate Cre
transcription. The albumin promoter is activated around em-
bryonic day 16.5 [18]; therefore, Ggcx exists in the liver of
GgcxDliver/Dliver mice until embryonic day 16.5. This will contribute
to a difference between liver-specific and systemic Ggcx-deficient
mice, the latter lack Ggcx from the beginning of embryogenesis.
Another possible reason that contributes to the difference between
these Ggcx-deficient mice is incomplete ablation of Ggcx in
GgcxDliver/Dliver mice. We detected slight residual GGCX activity in
the liver of GgcxDliver/Dliver mice (Figure 2D) and factors II and IX
activities were also detectable in the blood of GgcxDliver/Dliver mice
(Figure 3A). In another report using Alb-Cre mice, complete
ablation of target gene was observed in 2 months after birth [19].
Thus, it is assumed that residual Ggcx activity can also remain for
several weeks after birth. These slight residual activities may have
been vital for the survival of GgcxDliver/Dliver mice.
Both factor VII-deficient mice [22] and factor IX-deficient mice
[23] displayed bleeding diathesis. The factor IX-deficient mice
showed swollen extremities and extensive hemorrhagic lesions
following mechanical trauma, although they survived for at least
several weeks. In contrast, the factor VII-deficient mice survived to
term and followed a normal Mendelian inheritance pattern.
However, most of them died perinatally owing to intra-abdominal
hemorrhage within 24 hours, and the remaining neonates died
from intracranial hemorrhage in 24 days. Considering the
aggressive bleeding of factor VII-deficient mice, the residual
acitivity of Ggcx in GgcxDliver/Dliver mice may contribute to the
survival. Furthermore, Ggcx activity before embryonic day 16.5
may have some preventive effect against postnatal bleeding.
In regard to the phenotypes of conditional deficiency of
coagulation factors, factor VII-insufficient mice at the 0.7%
expression level compared with wild-type mice could survive to
adulthood despite displaying severely downregulated overall
thrombin production and caridiac fibrosis at a young adult age
[24]. Induction of prothrombin ablation in adulthood using Mx1-
Cre caused fatal hemorrhagic events particularly in heart and
brain [25]. Liver-specific Ggcx-deficient mice in the present study
exhibit a longer life span in comparison with that of prothrombin
deletion in adult mice, because the amount of coagulation factors
in Ggcx-deficient mice are substantially decreased but even
sufficient to survive for several weeks after birth. In comparison
with factor VII-insufficient mice, however, it is assumed that
severe insufficiency of multiple coagulation factors occurred in
liver-specific Ggcx-deficient mice simultaneously.
It is intriguing that mice lacking fibrinogen, the final effector of
the coagulation cascade, displayed similar phenotypes to those
seen in GgcxDliver/Dliver mice [26]. They suffered from spontaneous
abdominal hemorrhage, but long term survival was possible. In
fibrinogen-deficient mice, pregnant female ones died from vaginal
hemorrhage, which was also observed in GgcxDliver/Dliver mice.
Figure 1. Cre-recombinase-mediated tissue-specific excision of Ggcx. A, Strategy for homologous recombination. Targeting vector was
designed to flank exon 6 of the Ggcx gene, and frame shift was generated by excision with Cre recombinase. Two loxP sequences (triangles) were
inserted into introns 5 and 6. Neomycin cassette and EcoRI site were inserted into intron 6. B, Southern blot analysis of tail DNA. Homologous
recombinant allele generated a 7.4-kb fragment by EcoRI digestion. A representative figure is shown.
doi:10.1371/journal.pone.0088643.g001
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In this study, we observed longer life spans of female
GgcxDliver/Dliver mice compared with male GgcxDliver/Dliver mice.
Notably, this sexual dimorphism of life span was also observed
in fibrinogen-deficient mice [26], although the difference was
smaller than that of GgcxDliver/Dliver mice. Considering activities of
Ggcx in the livers of GgcxDliver/Dliver mice were not significantly
different between male and female (Figure 2D), this sexual
dimorphism may be owing to the difference in aggressiveness of
behavior between males and females. Typically, males are more
aggressive than females [27], which causing males more suscep-
tible to injury. Another explanation for the sexual dimorphism of
life span is the procoagulant activity of female sex hormone,
estrogen. Clinically estrogen administration as oral contraceptives
or hormone replacement therapy is known to be associated with
higher risk of venous thrombosis [28]. In experiment using rats,
estrogen was shown to prevent decline of prothrombin caused by
vitamin K deficiency [29]. This report suggests higher concentra-
tion of estrogen in female mice may ameliorate bleeding diathesis
due to Ggcx deficiency which is pathologically similar with vitamin
K deficiency.
Interestingly, we observed higher activities of Ggcx as well as
vitamin K-dependent coagulation factors in wild type male mice
Figure 2. Liver-specific ablation of Ggcx gene. A, The albumin promoter is active only in hepatocytes. Alb-Cre or wild type (WT) mice were
mated with ROSA26-LacZ mice. Livers were obtained postnatally from mice and stained with X-gal. b-galactosidase activity was detected in the
hepatocytes of the mouse born from mating of Alb-Cre and ROSA26-LacZ mice (right panel). Liver of the mouse born from wild type was shown as a
negative control (left panel). Representative figures are shown for each group. B, Genotyping using genomic tail DNA. Expected bands from Cre
recombinase, loxP sequence (floxed allele), and wild type allele are shown. In mouse #2, #4 and #5, both alleles were replaced with loxP containing
recombinant alleles, with at least one copy of Cre recombinase. A representative result is shown. C, Liver-specific ablation of Ggcx gene was
confirmed with PCR analysis. DNA samples derived from liver, spleen, kidney and heart of 6-month week old GgcxDliver/Dliver mice (4 male mice and 4
female mice) and control Ggcx+/+ mice (4 male mice and 4 female mice) were used as templates. D, Activity of Ggcx in the liver-specific Ggcx-deficient
mice. Microsome was prepared from the livers of 6-week old GgcxDliver/Dliver mice and control Ggcx+/+ mice of both sexes. The activity of Ggcx was
measured by 14CO2 incorporated into exogenous substrate in the presence of reduced vitamin K (222 mM). Bars represent the mean value 6 SEM
(n = 4). Differences between the mean values were analyzed using the unpaired Student’s t-test. **P,0.01.
doi:10.1371/journal.pone.0088643.g002
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than in wild type female mice (Figure 2D and 3A). In the study by
Wong et al. [30], some of the procoagulant factor activity levels
were higher in male mice than in female mice and were growth
hormone-dependent. In the study by Kundu et al., factor IX
activity might be higher in one-month-aged male mice compared
with one-month-aged females [31]. Since growth hormone has
been known to contribute to sexual dimorphism in liver protein
expression [32], it is assumed that the hormone will also exert
difference in Ggcx activity.
In human, two missense mutations of GGCX gene were reported
to cause hereditary bleeding disorder due to low activity of vitamin
K-dependent coagulation factors [33,34]. In our study about 60%
of female GgcxDliver/Dliver mice survived longer than 100 days
indicated small portion of residual Ggcx activity detected in the
liver of GgcxDliver/Dliver mice is sufficient to survive unless they got
injured or pregnant. This is compatible with the clinical
observation that patients with decreased carboxylase activity live
several years before diagnosis [33,34].
In the current study, we successfully generated mice exhibiting
liver-specific insufficiency of Ggcx activity. Because systemic Ggcx
knockout mice do not live long after birth, our animal model
enables to show the phenotype of liver-specific Ggcx deficiency for
the first time and also will open up the possibility to evaluate in
extra-hepatic organ-specific Ggcx activities using Cre recombinase
driven by proper organ-specific promoters. Recently, several
clinical and epidemiological studies have suggested extrahepatic
actions of vitamin K. Its fracture-prevention effect has been
proven in clinical studies [35,36], and vitamin K2 is used as a drug
for osteoporosis treatment in several Asian countries. In epidemi-
ological studies, low serum concentration of vitamin K was
reported to be correlated with osteoarthritis [37], dementia [38],
and coronary artery disease [39,40]. Moreover, a biosynthetic
enzyme of menaquinone, which is an active form of vitamin K,
was found to be expressed in extrahepatic organs [41]. These
discoveries along with the many Ggcx substrates expressed
throughout the body, suggest the extrahepatic function of Ggcx
is worth investigating. The Ggcx-floxed mice we created in this
study would be useful in clarifying vitamin K action in the whole
body.
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Figure 3. Bleeding diathesis in GgcxDliver/Dliver mice. A, Decreased
activity of coagulation factor in GgcxDliver/Dliver mice. Activities of factors
II and IX were significantly decreased in GgcxDliver/Dliver mice compared
with wild type (Ggcx+/+) mice. Bars represent the mean value 6 SEM
(n = 8). Differences between the mean values were analyzed using the
unpaired Student’s t-test. ***P,0.001. B, Prolonged bleeding time in
GgcxDliver/Dliver mice. Tail bleeding time was measured by a filter paper
method. GgcxDliver/Dliver mice continued bleeding for more than 30 min.
Gray triangle: 0 min; Black triangle: 10 min. A representative figure is
shown. C. Platelet counts of GgcxDliver/Dliver mice. Hematological
examination of male GgcxDliver/Dliver mice (n = 6), female GgcxDliver/Dliver
mice (n = 12), male wild type mice (n = 10), and female wild type mice
(n = 10) was performed. The platelet count was not significantly
different between wild type mice and GgcxDliver/Dliver mice. Bars
represent the mean value 6 SEM. NS: not significant.
doi:10.1371/journal.pone.0088643.g003
Figure 4. Shorter life span of GgcxDliver/Dliver mice. Cumulative life
spans of male GgcxDliver/Dliver mice (n = 10), female GgcxDliver/Dliver mice
(n = 11), male heterozygous littermates (Ggcx+/Dliver mice) (n = 12), and
female heterozygous littermates (Ggcx+/Dliver mice) (n = 12) were
calculated by the Kaplan-Meier method and compared using the log-
rank test. P-values were adjusted by the Bonferroni method. Life span of
male GgcxDliver/Dliver mice was significantly shorter (P,0.001) compared
with that of heterozygous mice. The life spans of female GgcxDliver/Dliver
mice were significantly longer than those of male GgcxDliver/Dliver mice
(P = 0.044).
doi:10.1371/journal.pone.0088643.g004
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26. Suh TT, Holmbäck K, Jensen NJ, Daugherty CC, Small K, et al. (1995)
Resolution of spontaneous bleeding events but failure of pregnancy in
fibrinogen-deficient mice. Genes Dev 9: 2020–2033.
27. Gatewood JD, Wills A, Shetty S, Xu J, Arnold AP, et al. (2006) Sex chromosome
complement and gonadal sex influence aggressive and parental behaviors in
mice. J Neurosci 26: 2335–2342.
28. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP (2002) Female hormones
and thrombosis. Arterioscler Thromb Vasc Biol 22: 201–210.
29. Matschiner JT, Willingham AK (1974) Influence of sex hormones on vitamin K
deficiency and epoxidation of vitamin K in the rat. J Nutr 104: 660–665.
30. Wong JH, Dukes J, Levy RE, Sos B, Mason SE, et al. (2008) Sex differences in
thrombosis in mice are mediated by sex-specific growth hormone secretion
patterns. J Clin Invest 118: 2967–2978.
31. Kundu RK, Sangiorgi F, Wu LY, Kurachi K, Anderson WF, et al. (1998)
Targeted inactivation of the coagulation factor IX gene causes hemophilia B in
mice. Blood 92: 168–174.
32. Waxman DJ, O’Connor C (2006) Growth hormone regulation of sex-dependent
liver gene expression. Mol Endocrinol 20: 2613–2629.
33. Brenner B, Sánchez-Vega B, Wu SM, Lanir N, Stafford DW, et al. (1998)
A missense mutation in gamma-glutamyl carboxylase gene causes combined
deficiency of all vitamin K-dependent blood coagulation factors. Blood 92:
4554–4559.
34. Spronk HM, Farah RA, Buchanan GR, Vermeer C, Soute BA (2000) Novel
mutation in the gamma-glutamyl carboxylase gene resulting in congenital
combined deficiency of all vitamin K-dependent blood coagulation factors.
Blood 96: 3650–3652.
35. Shiraki M, Shiraki Y, Aoki C, Miura M (2000) Vitamin K2 (menatetrenone)
effectively prevents fractures and sustains lumbar bone mineral density in
osteoporosis. J Bone Miner Res 15: 515–521.
36. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, et al. (2006)
Vitamin K and the prevention of fractures: systematic review and meta-analysis
of randomized controlled trials. Arch Intern Med 166: 1256–1261.
37. Neogi T, Booth SL, Zhang YQ, Jacques PF, Terkeltaub R, et al. (2006) Low
vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis
Rheum 54: 1255–1261.
38. Presse N, Shatenstein B, Kergoat MJ, Ferland G (2008) Low vitamin K intakes
in community-dwelling elders at an early stage of Alzheimer’s disease. J Am Diet
Assoc 108: 2095–2099.
39. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, et al.
(2004) Dietary intake of menaquinone is associated with a reduced risk of
coronary heart disease: the Rotterdam Study. J Nutr 134: 3100–3105.
40. Gast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, et al. (2009) A high
menaquinone intake reduces the incidence of coronary heart disease. Nutr
Metab Cardiovasc Dis 19: 504–510.
41. Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, et al. (2010)
Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic
enzyme. Nature 468: 117–121.
Phenotype of Liver-Specific Ggcx-Deficient Mice
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e88643
